Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-05 · accession 0001140361-23-000876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-06 | 2023-01-05 | ROIV | Venker Eric | Pres, COO | S - Sale | $8.02 | -24.0K | 729.4K | -3% | -$192.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-01-05 | S | D | 24,037 | $8.02 | 729,429 | D | — | — |